XML 47 R36.htm IDEA: XBRL DOCUMENT v3.24.0.1
Equity Based Compensation (Tables)
12 Months Ended
Dec. 31, 2023
Share-Based Payment Arrangement [Abstract]  
Schedule of Stock Option Activity
The following tables summarize the options issued, outstanding, and exercisable under our equity based compensation plans as of December 31, 2023 and 2022:

For the year ended December 31, 2023
Number of Options*Weighted Average Exercise Price*Intrinsic ValueWeighted Average Remaining Life
Outstanding, beginning of year296,650 $59.28 $686,035 6.14
Granted— — — — 
Exercised(16,343)1.90 203,269 — 
Canceled(26,601)72.85 — — 
Outstanding, end of year253,706 62.01 1,146,614 5.85
Exercisable, end of year232,041 56.42 1,139,545 5.72
Expected to vest, end of year21,665 $121.85 $7,069 7.30

For the year ended December 31, 2022
Number of Options*Weighted Average Exercise Price*Intrinsic ValueWeighted Average Remaining Life
Outstanding, beginning of year557,785 $66.12 $23,079,520 7.76
Granted10,405 27.74 — — 
Exercised(79,724)6.08 2,383,405 — 
Canceled(191,816)98.42 — — 
Outstanding, end of year296,650 59.28 686,035 6.14
Exercisable, end of year254,118 49.40 685,914 5.89
Expected to vest, end of year42,532 $117.80 $121 7.61

*Effective May 11, 2023, we performed a 1-for-38 reverse stock split. Share amounts have been retroactively restated.
Schedule of Weighted-average Assumptions used in the Black-Scholes Option Pricing Model
The following table represents the assumptions used for estimating the fair values of stock options granted to our employees, contractors, and non-employees under the Black-Scholes valuation model. The risk-free interest rate is based on the U.S. Treasury yield curve in effect on the grant date:

20232022
Risk-free interest rate
0.00%–0.00%
3.46%–3.91%
Expected volatility
0.00%–0.00%
115.75%–116.01%
Expected life (in years)0.006.00
Weighted average estimated fair value of options granted$— $27.74 
Schedule of Restricted Stock Awards and Restricted Stock Units
Restricted stock award and restricted stock unit transactions during the years ended December 31, 2023 and 2022 are summarized as follows:

For the year ended December 31, 2023
For the year ended December 31, 2022
Number of Shares*Weighted Average
Grant Date
Fair Value*
Number of Shares*Weighted Average
Grant Date
Fair Value*
Unvested shares, beginning of year342,940 $30.02 153,242 $160.36 
Granted356,679 18.00 400,363 22.42 
Vested(293,878)25.09 (36,537)144.78 
Forfeited or surrendered(49,138)35.35 (174,128)104.12 
Unvested shares, end of year356,603 $21.32 342,940 $30.02 

*Effective May 11, 2023, we performed a 1-for-38 reverse stock split. Share amounts have been retroactively restated.
Schedule of Restricted Stock Awards and Restricted Stock Units
Restricted stock award and restricted stock unit transactions during the years ended December 31, 2023 and 2022 are summarized as follows:

For the year ended December 31, 2023
For the year ended December 31, 2022
Number of Shares*Weighted Average
Grant Date
Fair Value*
Number of Shares*Weighted Average
Grant Date
Fair Value*
Unvested shares, beginning of year342,940 $30.02 153,242 $160.36 
Granted356,679 18.00 400,363 22.42 
Vested(293,878)25.09 (36,537)144.78 
Forfeited or surrendered(49,138)35.35 (174,128)104.12 
Unvested shares, end of year356,603 $21.32 342,940 $30.02 

*Effective May 11, 2023, we performed a 1-for-38 reverse stock split. Share amounts have been retroactively restated.